Skip to main content

Peer Review reports

From: Efficacy and safety of fixed doses of intranasal Esketamine as an add-on therapy to Oral antidepressants in Japanese patients with treatment-resistant depression: a phase 2b randomized clinical study

Original Submission
12 Feb 2021 Submitted Original manuscript
3 Mar 2021 Author responded Author comments - Yushin Tominaga
Resubmission - Version 2
3 Mar 2021 Submitted Manuscript version 2
20 Mar 2021 Reviewed Reviewer Report - Yuliya Knyahnytska
28 Mar 2021 Reviewed Reviewer Report
28 Apr 2021 Author responded Author comments - Yushin Tominaga
Resubmission - Version 3
28 Apr 2021 Submitted Manuscript version 3
10 May 2021 Reviewed Reviewer Report - Yuliya Knyahnytska
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
7 Oct 2021 Editorially accepted
25 Oct 2021 Article published 10.1186/s12888-021-03538-y

You can find further information about peer review here.

Back to article page